Global Vascular

Global Vascular develops implantable vascular stents for peripheral artery disease (PAD), and its lead product, the BioStealth Stent, uses next-generation "stealth" technology to reduce foreign-body recognition and restenosis. The company's devices are engineered to tolerate repeated bending, twisting and deformation in lower-limb arteries and aim to provide durable revascularization for long-segment occlusions, including below-the-knee lesions. Global Vascular focuses on the global PAD market, addressing tens of millions of patients worldwide with the goal of improving limb salvage and long-term walking function in aging populations.